Denise Visit 1: A 62-year-old woman with risk factors for osteoporosis

Title:

Denise Visit 1: A 62-year-old woman with risk factors for osteoporosis

Topic: Geriatrics
Relevant Terms: Osteoporosis, Postmenopausal Women
Primary Audience: Primary Care Physicians; Family Physicians; Internists; Nurse Practitioners; and Physician Assistants across the United States.
Launch Date: 04-Apr-13
Credits: 0.75 AMA PRA Category 1 Credit
0.75 AANP contact hour of continuing education
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Identifying risk factors for osteoporosis

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Define testing strategies for osteoporosis in postmenopausal women
  2. Identify candidates for pharmacologic treatment of postmenopausal osteoporosis 
  3. Evaluate and compare available therapies for osteoporosis 

    Faculty

    Nelson Watts, MD, FACP, MACE, CCD
    Director, Mercy Health Osteoporosis and Bone Health Services
    Cincinnati, OH
    Steven T. Harris, MD, FACP
    Clinical Professor of Medicine
    University of California San Francisco
    San Francisco, CA
    Cheryl L. Lambing, MD, FAAFP
    Faculty
    Family Medicine Residency
    Ventura County Medical Center
    Assistant Clinical Professor
    Department of Family Medicine
    University of California Los Angeles
    Los Angeles, CA
    PROGRAM OVERVIEW:
    About one-half of all postmenopausal women may have an osteoporosis-related fracture during their lives, posing an enormous health burden with an increasing elderly population. It is estimated that 1.5 million women in the United States have one or more osteoporosis-related fractures annually. Hip fractures elicit a particularly devastating toll, leading some long-term loss of mobility for 50% of women; require long-term care for approximately 25% of women; and increase 1-year mortality by up to 25%. Fractures at other sites can also result in serious morbidity. The patient's self-esteem and mood suffers as a result of pain, loss of mobility, changed body image, and loss of independence. Early detection of bone loss and appropriate management can help to prevent further bone loss, increased bone fragility, and fractures. Primary care clinicians have a major role to play in educating patients about osteoporosis, assessing risk, facilitating screening, and administering treatment. This activity will address the risk factors associated with osteoporosis and fracture, the role of BMD testing, and evidence based treatment strategies.
     
    DISCLOSURE POLICY STATEMENT:
    It is the policy of NACE to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. NACE assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.
     
    While NACE endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
     
    DISCLOSURE OF CONFLICTS OF INTEREST:
     
    Faculty
    Dr. Harris has received sponsorship from Eli Lilly & Company, Gilead Sciences, and Novartis. He is a consultant for Eli Lilly & Company, Gilead Sciences, and Merck.
     
    Dr. Watts is co-founder, stockholder, and director of OsteoDynamics; has received honoraria from Amgen, Eli Lilly & Company, Novartis, and Warner Chilcott; is a consultant for Abbott, Amgen, Bristol-Myers Squibb, Imagepace, Johnson & Johnson, Eli Lilly & Company, Medpace, Merck, Nitto Denko, Noven, Novo Nordisk, Pfizer/Wyeth, and Quark; and has received research support from Merck and NPS.

    Dr. Lambing is a speaker for Amgen.
     
    Planning Committee
    Gregg Sherman, MD, has no real or apparent conflicts of interest to report. 
     
    Harvey Parker, PhD, has no real or apparent conflicts of interest to report. 
     
    Josh Kilbridge has no real or apparent conflicts of interest to report. 
     
    DISCLOSURE OF UNLABELED USE:
    NACE requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
     
    DISCLAIMER
    The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of NACE. The information is presented for the purpose of advancing the attendees' professional development.
     
    ACCREDITATION STATEMENT:
    The National Association for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
     
    National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. AANP Provider Number 121222. 
     
    This CME activity was planned and produced in accordance with the ACCME Essentials and the AANP CE Standards and Policies and AANP Commercial Support Standards.
     
    For CME questions, please contact: NACE at info@naceonline.com
     
    Contact this CME provider for privacy and confidentiality policy statement information at:
     
    http://www.naceonline.com/privacy_policy.php
     
    CREDIT DESIGNATION STATEMENT:
    NACE designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.
     
    National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.75 hrs contact hours of continuing education (which includes 0.25 hours of pharmacology).
     
    TO OBTAIN CME CREDITS:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
    • You must score 60% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
    COURSE VIEWING REQUIREMENTS:
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    COURSE FORMAT/MEDIUM: Internet CME Activity
     
    ESTIMATED TIME TO COMPLETE: 45 minutes
     
    ACKNOWLEDGEMENT:
    This activity is sponsored by National Association for Continuing Education.
     
                                     
    This activity is supported by an educational donation provided by Amgen.
     
     
    If you have any questions regarding this activity, send an email to info@naceonline.com.
       
    Copyright © 2013 National Association for Continuing Education. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of NACE is prohibited.